G. Paré, C. Sicotte, Hélène Jacques
semanticscholar +1 more source
Decreased Serum 5‐HT: Clinical Correlates and Regulatory Role in NMJ of MG
ABSTRACT Objective Although 5‐Hydroxytryptamine (5‐HT) indirectly stimulates muscle contraction and participates in regulating Acetylcholine receptor (AChR) cluster homeostasis in cellular, animal, and clinical studies, evidence regarding its potential to modulate muscle contraction in myasthenia gravis (MG) remains limited.
Xinru Shen +18 more
wiley +1 more source
Phenotypic and molecular characterisation of CDK13-related congenital heart defects, dysmorphic facial features and intellectual developmental disorders [PDF]
Andrews, Marisa V +2 more
core +2 more sources
Clinical Characteristics and Outcomes of Early‐Onset Versus Late‐Onset LGI1‐Antibody Encephalitis
ABSTRACT Background Leucine‐rich glioma‐inactivated 1 antibody (LGI1‐Ab) encephalitis predominantly affected older individuals, but has also been reported in younger patients. However, the demographic, clinical, and prognostic characteristics of early‐onset LGI1‐Ab encephalitis have yet to be systematically elucidated. This study aims to systematically
Yu Kong +7 more
wiley +1 more source
Enhancing clinical laboratory quality in Rwanda: addressing healthcare expectations and future fitness - insights from observations and perspectives of physicians and laboratory professionals. [PDF]
Nzabahimana I +3 more
europepmc +1 more source
The Incremental Development of a MUMPS-Based Clinical Laboratory Information System
Philip Blume
openalex
Assessing the Impact of Laboratory Information System on Clinical Workflow and Patient Outcomes
Stephanie Antonio +5 more
openalex +2 more sources
Clinical Knowledge Discovery in Hospital Information Systems: Two Case Studies
S. Tsumoto
semanticscholar +1 more source
GloPID-R report on Chikungunya, O\u27nyong-nyong and Mayaro virus, part I: Biological diagnostics [PDF]
Diamond, Michael S, et al,
core +1 more source
ABSTRACT Background There is growing recognition of the potential of plasma proteomics for Alzheimer's Disease (AD) risk assessment and disease characterization. However, differences between proteomics platforms introduce uncertainties regarding cross‐platform applicability.
Manyue Hu +9 more
wiley +1 more source

